Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: Results from the REDECT trial Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Carcinoma, Renal Cell
  • Iodine Radioisotopes
  • Kidney Neoplasms
  • Radiopharmaceuticals

abstract

  • This study represents (to the best of our knowledge) the first clinical validation of a molecular imaging biomarker for malignancy. (124)I-girentuximab PET/CT can accurately and noninvasively identify ccRCC, with potential utility for designing best management approaches for patients with renal masses.

publication date

  • January 10, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.41.2445

PubMed ID

  • 23213092

Additional Document Info

start page

  • 187

end page

  • 94

volume

  • 31

number

  • 2